HEXO Is Surging Ahead of Earnings: Should You Be Buying?

 HEXO Corp (TSX:HEXO)(NYSE:HEXO) is releasing its quarterly results later this week, which will be a big test for the company.

| More on:

It could be a big week for HEXO (TSX:HEXO)(NYSE:HEXO), as the pot producer releases its third-quarter earnings on Thursday before the markets open. Shares of the company have been soaring over the past month, as they’re up more than 70%. On Monday, the stock was up more than 20% by midday. Here’s how it’s done of late compared to its peers:

HEXO Chart

The stock’s been performing very well recently, but over the past year the results tell a bit of a different story:

HEXO Chart

What can we attribute these gains to?

The markets as a whole have been fairly bullish over the past few weeks. There’s been growing optimism, as cities in North America have been reopening. There’s hope that the COVID-19 pandemic may not have as disastrous an impact on the economy as once feared. And for stocks like HEXO that have incurred significant losses over the past year, it’s made them more attractive buys in the process. After all, if the economy’s doing better, then there will be more consumers making discretionary purchases, and that means more pot buying.

But where the stock goes from here will largely depend on how it does in its upcoming earnings release.

What investors should look for when the company releases earnings

HEXO has incurred a loss in each of its last 10 quarterly results. It would be nothing short of shocking if the company were to post a profit, especially since in its last quarter it had a mammoth $298 million loss. That was due to some sizeable writedowns that weighed the company’s bottom line down. However, HEXO had a negative gross margin, so profitability wasn’t going to happen with or without the writedowns.

It’s a given that HEXO will occur a loss in its third quarter; the only question is how big it will be.

The one thing investors should keep an eye out for is impairments and whether they reoccur, and if so, to what degree? Another series of large writedowns could send the stock crashing despite its recent gains. Another area investors will want to look for is whether HEXO’s growing its sales — something that hasn’t been an automatic in the cannabis industry this year. HEXO’s value brand should help take revenue away from the black market, but it may not be enough to offset the downturn that COVID-19 may have caused in recent months.

Is HEXO a buy?

Investors are taking on a big risk when buying a stock that’s rallying significantly heading into earnings. It’s a sign that there’s a lot of excitement heading into earnings, and that also means expectations will be high for the company to do well. Canopy Growth didn’t post impressive sales numbers when it released its most recent earnings, and that was even as the industry saw lots of panic buying in March. HEXO’s earnings will go until the end of April when panic buying slowed.

Despite HEXO’s decline over the past year, there are more reasons to expect a poor showing in Q3 than there are that the company will beat expectations. And that’s why I wouldn’t get on the bandwagon, especially as the stock’s near its three-month high. Investors could incur significant losses if the company doesn’t post an amazing performance this week.

Fool contributor David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »